Tealwood Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Tealwood Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$1.28M	Sell	8,380 -56	-0.7%	-$8.66K	0.51%	98
2020 Q4	$1.32M	Sell	8,436 -542	-6%	-$69.6K	0.62%	75
2020 Q3	$1.03M	Sell	8,978 -10	-0.1%	-$1.08K	0.67%	63
2020 Q2	$1.01M	Sell	8,988 -6,684	-43%	-$710K	0.67%	62
2020 Q1	$1.41M	Buy	15,672 +383	+3%	+$37.6K	0.8%	67
2019 Q4	$1.65M	Sell	15,289 -591	-4%	-$63.2K	0.69%	79
2019 Q3	$1.55M	Buy	15,880 +88	+0.6%	+$9.92K	0.67%	83
2019 Q2	$2.07M	Buy	15,792 +3,932	+33%	+$507K	0.84%	66
2019 Q1	$1.6M	Buy	11,860 +1,799	+18%	+$224K	0.68%	80
2018 Q4	$980K	Sell	10,061 -2,159	-18%	-$255K	0.47%	77
2018 Q3	$1.7M	Sell	12,220 -392	-3%	-$49.2K	0.64%	77
2018 Q2	$1.57M	Buy	12,612 +31	+0.2%	+$3.62K	0.61%	79
2018 Q1	$1.4M	Buy	12,581 +2,375	+23%	+$284K	0.56%	80
2017 Q4	$1.22M	Sell	10,206 -1,249	-11%	-$152K	0.45%	86
2017 Q3	$1.61M	Buy	+11,455	New	+$1.56M	0.58%	79

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tealwood Asset Management's ALXN Position: Q1 2021 in Review

Tealwood Asset Management reduced its Alexion Pharmaceuticals (ALXN) stake by 0.66% in Q1 2021, selling an estimated $8.66K and leaving 8,380 shares worth $1.28M. The position accounts for 0.51% of the portfolio, ranked #98.

Tealwood Asset Management first reported a position in ALXN in Q3 2017 and has held it in 15 quarters since. The position peaked at $2.07M in Q2 2019. 752 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

Tealwood Asset Management held 8,380 shares of Alexion Pharmaceuticals worth $1.28M as of Q1 2021.
Tealwood Asset Management sold 56 Alexion Pharmaceuticals shares in Q1 2021, an estimated $8.66K.
Alexion Pharmaceuticals made up 0.51% of Tealwood Asset Management's portfolio in Q1 2021, its #98 holding.
Tealwood Asset Management first reported a position in Alexion Pharmaceuticals in Q3 2017 and has held it in 15 quarters since.
Tealwood Asset Management's Alexion Pharmaceuticals position peaked at $2.07M in Q2 2019.
752 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Tealwood Asset Management's 13F filing for Q1 2021, filed 21 Jun 2021.